4Ohta M, Inoue H, Cotticelli M G, et al. The FHIT gene, spanning the chromosome 3P14. 2 fragile site and renal cell carcinoma-associated (3 : 8) breakpoint is abnormal in digestive tract cancers[J]. Cell, 1996,84(4) : 587-597.
5Hao X P, Willis J E, Pretlow T G, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions [J]. Cancer Res,2000,60(1):18-21.
6Huntsman D, Resau J H, Klineberg E, et al. Comparison of C-Met expression in ovarian epithelial tumors and normal epithelial of the female reproductive tract by quantitative laser scan microscopy[J]. Am J Pathol,1999.155(2) :343-348.
7Yamaguchi R, Yano H, Lemura A, et al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma[J]. Hepatology, 1998,28 ( 1 ) : 68-77.
8Maggiora P, Lorenzato A, Fracchioli S, et al. The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness[J]. Exp Cell Res, 2003, 288(2): 382-389.
9Ayhan A, Ertunc D, Tok E C, et al. Expression of the C-Met in advanced epithelial ovarian cancer and its prognostic significance [J]. Gynecol Cancer,2005,15(4) :618-623.
10Michael D, Beer DG, Wilke CW, et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas[ J ]. Oncogene, 1997,15 (14) : 1653-1659.
